Metabolic syndrome

From Citizendium
Revision as of 03:21, 17 November 2007 by imported>Pierre-Alain Gouanvic (Definition from the WHO; ref: consensus statement; original ref, on the insulin resistance syndromes put in context)
Jump to navigation Jump to search

The metabolic syndrome, also known as the dysmetabolic syndrome, or metabolic syndrome X, is a major public health concern worlwide. The growing obesity epidemic is its most noticeable effect,[1] but the metabolic syndrome can be present in the absence of frank obesity. Almost one fourth of Americans have metabolic syndrome, and the proportion keeps raising.[2]

The metabolic syndrome is defined by the World Health Organisation using the following criteria :

  • Insulin resistance, identified by one of the following:
    • Type 2 diabetes
    • Impaired fasting glucose
    • Impaired glucose tolerance
    • or, for those with normal fasting glucose levels (<110mg/dL), glucose uptake below the lowest quartile for background population under investigation under hyperinsulinemic, euglycemic conditions
  • in conjunction with any two of the following:
    • Antihypertensive medication and/or high blood pressure (≥140mmHg systolic or ≥90mmHg diastolic)
    • Plasma triglycerides ≥150mg/dL (≥1.7mmol/L)
    • HDL cholesterol <35mg/dL (0.9mmol/L) in men or <39mg/dL (1.0mmol/L) in women
    • BMI (Body Mass Index) >30kg/m² and/or waist:hip ratio >0.9 in men, >0.85 in women
    • Urinary albumin excretion rate ≥20μmg/g or albumin: creatinine ratio ≥30 mg/g.[3]

The metabolic syndrome is thus a cluster of risk factors for diabetes and cardiovascular diseases. The syndrome includes proinflammatory and prothrombotic features.[3]

The metabolic syndrome could also promote the development of cancer, polycystic ovary syndrome (PCOS), and nonalcoholic fatty liver disease".[4]

References

  1. ABC News: The World Is Getting Rounder. Retrieved on 2007-11-17.
  2. What Is Metabolic Syndrome?. Retrieved on 2007-11-17.
  3. 3.0 3.1 Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C (2004). "Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition". Arterioscler. Thromb. Vasc. Biol. 24 (2): e13–8. DOI:10.1161/01.ATV.0000111245.75752.C6. PMID 14766739. Research Blogging.
  4. Biddinger SB, Kahn CR (2006). "From mice to men: insights into the insulin resistance syndromes". Annu. Rev. Physiol. 68: 123–58. DOI:10.1146/annurev.physiol.68.040104.124723. PMID 16460269. Research Blogging.